IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES TAKEDA
Pharmaceutical Sales by Country and Subsidiary
Share of
Regional
Corporate Sales
%
Percentage
Growth Sep
07/Sep 08
USD USD FIXED
RATE
TOTAL SALES 100.0 10 5
U.S.A. 55.6 5 5
TAKEDA PHARM USA 95.6 3 3
MILLENNIUM PHARM 4.4 39 39
JAPAN 32.4 16 5
TAKEDA YAKUHIN KOG 96.5 16 5
NIHON SEIYAKU TOKY 3.3 13 2
WAKO JUNYAKU KOGYO 0.1 21 9
NIHON SEIYAKU KOGY 0.0 8 -2
FRANCE 2.7 3 -9
TAKEDA S.A. 100.0 3 -9
GERMANY 2.6 21 7
TAKEDA PHARMA 100.0 21 7
ITALY 2.0 20 6
TAKEDA ITALIA FARM 100.0 20 6
UNITED KINGDOM 1.5 38 38
TAKEDA 100.0 38 38
PUERTO RICO 0.6 18 18
TAKEDA PHARM USA 99.1 18 18
MILLENNIUM PHARM 0.9 -9 -9
AUSTRIA 0.5 23 8
TAKEDA PHARMA 100.0 23 8
This ta ble shows the break down of the com pany’s phar ma ceu ti cal sales in terms of lead ing coun tries and
sub sid iar ies. Sta tis tics for coun try share of cor po rate rev e nue, sub sid iary share of coun try rev e nue, US
dol lar and US dol lar fixed rate growth over the pre vi ous twelve month pe riod are pre sented. Sales data
cov ers the pe riod for the twelve months to September 2008.
All of the sub sid iar ies men tioned above are 100%-owned by Takeda ex cept Nihon Seiyaku Kogy and
Nihon Seiyaku Toky (both 82%-owned by Takeda); Takeda Italia Farm (77%-owned by Takeda) and
Wako Junyaku Kogy (31%-owned by Wako Junyaku Kogyo). Sales for a sub sid iary are al lo cated to the
cor po ra tion with the ma jor ity shareholding. In re la tion ships where there is a 50:50 shareholding, how -
ever, sales will con tinue to be split 50:50 be tween the two own ing corporations.
© 2009 IMS Health In cor po rated or its af fil i ates Page 86